REGIS CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data REGIS CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	1,692	1,235	1,069	670	412	276	233	203	210	224
General and administrative	157	174	177	131	96.4	65.3	50.8	45.4	46.8	42
Operating income	12.6	-5.14	-22.1	-145	-94.7	-28.9	8.78	20.9	19.9	24.4
Interest expense	8.58	10.5	4.8	7.52	13.2	12.9	22.1	25.4	20.3	20.7
Other non-operating income	1.47	5.2	1.73	3.35	15.9	-0.3	1.36	-0.17	1.85	1.1
Pre-tax income	5.93	-10.2	-22.3	-177	-109	-44.4	-12	89.9	1.54	5.87
Income tax	9.22	-69.8	-2.15	-4.62	-5.43	2.02	-0.66	0.87	-115	-1.07
Income from continuing operations	-3.3	59.6	-20.1	-172	-103	-46.5	-11.3	89.1	117	6.94
Net income	-18.5	6.44	-14.2	-171	-113	-85.9	-7.39	91.1	124	6.94
EBITDA	53.3	34.3	11.1	-112	-76.8	-22.4	16	24.3	22.8	28.3
EPS, basic	-8.00	2.80	-6.80	-95.40	-63.00	-39.40	-3.18	38.93	52.26	2.76
EPS, diluted	-8.00	2.80	-6.80	-95.40	-63.00	-39.40	-3.18	38.34	46.10	2.41
Shares, basic (weighted)	2.32	2.33	2.09	1.8	1.8	2.18	2.32	2.34	2.36	2.52
Shares, diluted (weighted)	2.32	2.35	2.09	1.8	1.8	2.18	2.32	2.38	2.68	2.88

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	171	110	70.1	114	19.2	17	9.51	10.1	17	26
Receivables	19.7	52.4	30.1	31	26.3	14.5	10.9	9.43	9.47	9.27
Inventory	98.4	79.4	77.3	62.6	20.6	3.11	1.68	0.82	2.8	2.48
Other current assets	48.1	47.9	33.2	19.1	17	14	16.8	21.7	21.3	19.6
Total current assets	370	290	211	226	86.7	48.7	37.2	42.1	50.5	57.4
Property, plant and equipment	123	99.3	78.1	57.2	16.9	12.8	6.42	3.66	10.1	9.29
Lease right-of-use assets				786	611	494	361	288	230	176
Goodwill	417	413	346	227	230	174	174	173	183	183
Intangible assets	12	10.6	8.76	4.58	3.76	3.23	2.78	2.43	5.83	4.73
Other non-current assets	61.8	37.6	34.2	40.9	41.4	36.5	26.3	21.3
Total assets	1,011	857	683	1,343	996	769	607	530	599	547
Accounts payable	54.5	57.7	47.5	50.9	27.2	15.9	14.3	12.7	20.8	19.6
Accrued liabilities	110	101	80.8	48.8	51.2	33.8	30.1	21.6	19.1	15.5
Deferred revenue		8.66	7.41	8.16	8.16	7.81	7.15	5.1	4.31	3.61
Short-term debt					0			0	1.1	3
Total current liabilities	178	158	128	237	198	153	126	104	102	91.9
Long-term debt	121				187	180	177	99.5	110	114
Lease liabilities			0	680	518	408	292	231	179	130
Other non-current liabilities	197	122	111	94.1	75.1	59	49	40	22.7	16.9
Total liabilities	503	370	359	1,217	979	800	644	474	413	353
Total debt	121	90	90	178	187	180	177	99.5	111	117
Paid-in capital	214	194	47.2	22	25.1	62.6	66.8	69.7	75.2	77.2
Retained earnings	288	280	266	94.5	-19.4	-105	-113	-21.6	102	109
Other comprehensive income	3.34	9.66	9.34	7.45	9.54	9.46	9.02	8.58	8.29	7.62
Shareholders' equity						-31	-36.7	56.8	186	194
Total equity	493	486	324	126	17	-31	-36.7	56.8	186	194
Total liabilities and equity	1,011	857	683	1,343	996	769	607	530	599	547
Shares outstanding	2.32	2.26	1.84	1.78	1.79	45.5	2.28	2.28	2.44	2.5

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-18.5	6.44	-14.2	-171	-113	-85.9	-7.39	91.1	124	6.94
Depreciation and amortization	40.7	39.4	33.3	33.1	17.9	6.5	7.19	3.4	2.88	3.86
Stock-based compensation	13.1	8.27	9	3.28	3.25	1.33	2.32	1.56	1.94	0.85
Deferred income tax	7.96	-80.2	-9.81	-3.93	-3.39	0.39	-0.01	0.52	-114	-1.05
Change in receivables	0.72	-12.1	-17.3	-3.9	-0.28	11.9	0.94	0.85	-0.04	0.18
Change in inventory	4.01	13.9	-8.49	-2.26	17.9	7.89	-0.18	0.85	0.87	0.32
Change in payables	-0.68	-1.1	-5.84	4.59	-21.7	-11	-2.28	0.83	-0.5	-0.85
Cash from operations	58.3	2.59	-17.5	-86.4	-99.9	-38.6	-7.89	-2.04	13.7	13.1
Capital expenditures	-26.6	-29.6	-31.6	-37.5	-11.5	-5.32	-0.48	-0.38	-1.3	-1.97
Acquisitions							0	0	-18.6	0
Sales and maturities of investments	0.5	0	0
Cash from investing	-30.2	-1.05	87.8	61	-2.1	7.68	4.02	1.62	-11.5	-1.97
Debt repaid	0	-124	0	-126	-0.59	-16.9	-11.1	-96.5	-1.13	-2.74
Stock issued					0	37.2	0	0	0	0.61
Share buybacks	0	-24.8	-153	-28.2	0
Cash from financing	-6.85	-62.2	-127	56.2	7.78	29.4	-2.15	8.36	3.59	-2.26
Exchange rate effect	0.94	-0.51
Net change in cash	22.2	-61.2	-56.4	30.5	-93.7	-1.69	-6.07	7.92	5.89	8.79
Free cash flow	31.8	-27	-49.1	-124	-111	-44	-8.37	-2.42	12.4	11.1
Interest paid	7.29	7.02	4.41	7.39	11.9	11.8	15.5	19	11.5	11.3
Income taxes paid	2.31	2.4	2.1	2.15	-2.64	-1.4	0.27	-0.89	0.46	0.23

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $28.37 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	10.9%	Operating income / revenue.
EBITDA margin	12.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.6%	Pre-tax income / revenue.
Net margin	3.1%	Net income / revenue.
FCF margin	5.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.8%	Cash from operations / revenue.
Effective tax rate	-18.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.2%	Net income / average total assets.
Return on invested capital (ROIC)	6.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.9%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-11.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	22.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	40.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	24.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	21.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-94.4%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-94.8%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-4.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-10.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	4.4%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-8.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-11.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	7.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	7.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	9.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.62x	Current assets / current liabilities.
Quick ratio	0.38x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.28x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.60x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	21.4%	Total debt / total assets.
Liabilities / assets	64.6%	Total liabilities / total assets.
Net debt	$91.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.22x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.18x	Operating income / interest expense.
Working capital	-$34.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	34.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$6.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.39x	Revenue / average total assets.
Fixed asset turnover	23.2x	Revenue / average property, plant and equipment.
Receivables turnover	24.0x	Revenue / average receivables.
Days sales outstanding	15 days	365 x average receivables / revenue.
FCF conversion	160.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	15.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.41	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$2.76	Net income per basic share, as reported (split-adjusted).
Revenue per share	$77.97	Revenue / diluted weighted shares.
FCF per share	$3.87	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.55	Cash from operations / diluted weighted shares.
Book value per share	$77.56	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.55	Tangible book value / shares outstanding.
Cash per share	$10.42	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$70.9M	Share price x shares outstanding.
Enterprise value	$162.0M	Market cap + total debt - cash - short-term investments.
P/E	10.2x	Market cap / net income. Only when net income is positive.
P/S	0.32x	Market cap / revenue.
P/B	0.37x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	11.1x	Market cap / tangible book value, when positive.
P/FCF	6.37x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.41x	Market cap / cash from operations, when positive.
EV/Sales	0.72x	Enterprise value / revenue.
EV/EBIT	6.63x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.72x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	15.7%	Free cash flow / market cap.
Earnings yield	9.8%	Net income / market cap (the inverse of P/E).

What was REGIS CORP's revenue in fiscal 2026?

REGIS CORP reported revenue of $224.5M for fiscal 2026, 6.8% higher than the year before.

Was REGIS CORP profitable in fiscal 2026?

Yes. Net income was $6.9M, a net margin of 3.1%.

How much free cash flow did REGIS CORP generate in fiscal 2026?

Cash from operations of $13.1M minus capital expenditures of $2.0M left free cash flow of $11.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to REGIS CORP